Michael F. Holick MD, Ph.D
Dr. Holick has made numerous contributions to the field of the biochemistry, physiology, metabolism, and photobiology of vitamin D for human nutrition. Dr. Holick has established global recommendations advising sunlight exposure as an integral source of vitamin D. He has helped increase awareness in the pediatric and medical communities regarding vitamin D deficiency pandemic, and its role in causing not only metabolic bone disease, and osteoporosis in adults, but increasing risk of children and adults developing preeclampsia, common deadly cancers, schizophrenia, infectious diseases including TB and influenza, autoimmune diseases including type 1 diabetes and multiple sclerosis, type 2 diabetes, stroke and heart disease.
Alexandros Makriyannis, Ph.D.
Professor Alex Makriyannis is the George Behrakis Chair of Pharmaceutical Biotechnology at Northeastern University, Boston, MA, and is the Founder and Director of the Center for Drug Discovery. Dr Makriyannis has expertise in drug design and synthesis, molecular recognition, membrane biophysics, membrane protein purification and characterization. He is a highly successful medicinal chemist and is well recognized internationally for his important contributions in endocannabinoid research, helping to elucidate the psychoactive properties of some of these substances. Some of his compounds are in advanced preclinical trials for the treatment of metabolic disorders and liver function, neuropathic pain, addiction and neurodegenerative diseases. Dr. Makriyannis’ research has been reported in over 470 publications and his group has filed more than 40 patents
Ethan Will Taylor, Ph.D.
Professor Ethan Will Taylor is a pharmacologist, computational chemist and virologist. He is currently Professor of Chemistry and Biochemistry at the University of North Carolina at Greensboro, where he also served as a founding member of the Department of Nanoscience and as Director of the Biosafety Level 3 Laboratory. Dr. Taylor's research has ranged from the neurochemistry of serotonin to various aspects of emerging infectious diseases including HIV, Ebola, Zika, and the SARS coronaviruses. He is best known for his work on the role and mechanisms of the trace element selenium and other dietary factors in reducing the pathophysiological effects of RNA viruses.
David Tomen is a recognized leading expert in Nootropic supplementation, substances that are claimed to improve cognitive function, particularly executive functions, memory, creativity, or motivation, in healthy individuals. He has joined the BHC Scientific Advisory Board because he identifies with and supports the Mission, Values, and initiatives of the Company. David is a frequent guest at many health and wellness symposiums and often found on Podcasts and Social Media sites where he enlightens and inspires individuals in well-being. David has authored two books, “Head First” and “The Secrets to Optimizing Your Brain”
Juan Celidonio Ruiz Macedo
Juan Celidonio Ruiz Macedo is an ethnobotanist with over 40 years of experience working in Peru. Mr. Macedo has a Masters degree in forest science from the Universidad Nacional de la Amazonía Peruana (UNAP). Mr. Macedo may be perhaps the most knowledgeable botanist in the region, with an encyclopedic botanical and rich ethnobotanic knowledge including many plants with medicinal and psychedelic properties. He trained with world renown pioneer Richard Schultes. Mr. Macedo is the Co-Founder for the Schultes Center, and the curator of the Herbarium Amazonense, the UNAP comprehensive library of Amazonian plant specimens. https://www.schultescenter.org/our-team